Summer Sale
50% off Premium Yearly
Opinions John Hood
Horizon's Medical MarijuanaHMMJ.TODON'T BUYJan 19, 2018
Stock price when the opinion was issued
As of Jun 19, 2026. Market Open.
You might be interested:
This asset class has been down for 5 years during a long period of investor apathy. But when an asset class has been down for longer than 3 years, you start to consider it. HMMJ has US exposure where there is growing public support for legalizing canopy. Maybe start with a small position. This is a volatile sector.
HMMJ vs. HMUS. A monstrous opportunity, but you're going to suffer volatility. Go slow, get in over time, and keep it to a smaller proportion of your portfolio. Market weighted. The US exposure is to companies operating legally, and there can't be any recreational use. With HMUS, you're tapping into a bigger market. For example, Charlotte's Web is planning to sell CBD infused products through Kroeger. This scale dwarfs the whole Canadian market. Valuations are high because of the growth potential. If you're a marijuana investing aficionado, you'd want to own both.
You have to remember, this ETF and the companies in it, none are making any money. Secondly, we don't know what price this is going to come out at or the distribution network. We don't know what the margins of profit are going to be. On that basis, he won't buy this. He is an investor, not a gambler. If you wouldn't take your money to a gambling casino, then don't put it in this stock.